GABA Transporter 1 (GAT1) (Middle Region) Peptide
Quick Overview for GABA Transporter 1 (GAT1) (Middle Region) Peptide (ABIN8101218)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- SLC6A1 Peptide - middle region
-
Sequence
- LIILFFRGVT LPGAKEGILF YITPNFRKLS DSEVWLDAAT QIFFSYGLGL
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-SLC6A1 Antibody(ARP43833_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SLC6A1 (GAT1) (GABA Transporter 1 (GAT1))
-
Background
-
Background Information: SLC6A1 terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine.
Alternative Symbols: GABATHG, GABATR, GAT1
-
Molecular Weight
- 67kDa
-
Gene ID
- 6529
-
NCBI Accession
- NP_003033
-
UniProt
- P30531
Target
-